HomeUBX • NASDAQ
add
Unity Biotechnology Inc
Previous close
$1.49
Day range
$1.45 - $1.52
Year range
$1.22 - $2.99
Market cap
25.52M USD
Avg Volume
48.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.88M | -19.17% |
Net income | -5.79M | -9.68% |
Net profit margin | — | — |
Earnings per share | -0.34 | 55.26% |
EBITDA | -7.37M | 27.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 36.33M | -56.43% |
Total assets | 58.86M | -48.48% |
Total liabilities | 34.88M | -37.31% |
Total equity | 23.99M | — |
Shares outstanding | 16.79M | — |
Price to book | 1.04 | — |
Return on assets | -30.50% | — |
Return on capital | -36.01% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -5.79M | -9.68% |
Cash from operations | -5.18M | 54.20% |
Cash from investing | -7.19M | -133.79% |
Cash from financing | — | — |
Net change in cash | -12.37M | -220.88% |
Free cash flow | -2.11M | 70.21% |
About
Unity Biotechnology, Inc. is a publicly traded American biotechnology company that develops drugs that target senescent cells. Wikipedia
Founded
2011
Headquarters
Website
Employees
19